A Phase 3 Study of Amifampridine Phosphate in Patients With Lambert Eaton Myasthenic Syndrome (LEMS)

This study is currently recruiting participants.

Study NCT01377922 Information provided by BioMarin Pharmaceutical

First Received: June 17, 2011 Last Updated: May 8, 2012 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	August 2016
Estimated Primary Completion Date:	June 2014 (Final data collection date for primary outcome measure)